{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:48:02Z","timestamp":1794019682506,"version":"4.8.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["21-73-10230"],"award-info":[{"award-number":["21-73-10230"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejmech.2024.116283","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T03:04:55Z","timestamp":1709607895000},"page":"116283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A first-in-class \u03b2-glucuronidase responsive conjugate for selective dual targeted and photodynamic therapy of bladder cancer"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6015-099X","authenticated-orcid":false,"given":"Vasilii F.","family":"Otvagin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubov V.","family":"Krylova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina N.","family":"Peskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia S.","family":"Kuzmina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina A.","family":"Fedotova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Nyuchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya V.","family":"Romanenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar I.","family":"Koifman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey Z.","family":"Vatsadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-G\u00fcnther","family":"Schmalz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina V.","family":"Balalaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey Yu","family":"Fedorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10061","key":"10.1016\/j.ejmech.2024.116283_bib1","first-page":"2796","volume":"388","author":"Kamat","year":"2016","journal-title":"Bladder Cancer, Lancet"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116283_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non\u2013muscle-invasive bladder cancer: from epidemiology to treatment strategy","volume":"56","author":"van Rhijn","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejmech.2024.116283_bib3","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116283_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/tcr.201600121","article-title":"Photodynamic therapy: past, present and future","volume":"17","author":"Chilakamarthi","year":"2017","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ejmech.2024.116283_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","article-title":"Photodynamic therapy \u2013 mechanisms, photosensitizers and combinations","volume":"106","author":"Kwiatkowski","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116283_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.6060\/mhc224870k","article-title":"Synthesis strategy of tetrapyrrolic photosensitizers for their practical application in photodynamic therapy","volume":"15","author":"Koifman","year":"2022","journal-title":"Macroheterocycles"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116283_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/php.12952","article-title":"Apoptosis, paraptosis and autophagy: death and survival pathways associated with photodynamic therapy","volume":"95","author":"Kessel","year":"2019","journal-title":"Photochem. Photobiol."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116283_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41419-022-04851-4","article-title":"Which cell death modality wins the contest for photodynamic therapy of cancer?","volume":"13","author":"Mishchenko","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116283_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818785512","article-title":"Photodynamic therapy mediated by aloe-emodin inhibited angiogenesis and cell metastasis through activating MAPK signaling pathway on HUVECs","volume":"17","author":"Chen","year":"2018","journal-title":"Technol. Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116283_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future","volume":"9","author":"Alzeibak","year":"2021","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"5","key":"10.1016\/j.ejmech.2024.116283_bib11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/php.13300","article-title":"Photodynamic therapy and immune checkpoint blockade","volume":"96","author":"Cramer","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejmech.2024.116283_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.102091","article-title":"Features of third generation photosensitizers used in anticancer photodynamic therapy: review","volume":"34","author":"Mfouo-Tynga","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116283_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/php.13726","article-title":"Photodynamic therapy for bladder cancers, A focused review","volume":"99","author":"Rahman","year":"2023","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejmech.2024.116283_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/molecules27030731","article-title":"Advances in management of bladder cancer\u2014the role of photodynamic therapy","volume":"27","author":"Kubrak","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116283_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.euf.2018.08.005","article-title":"Photodynamic therapy in the treatment of bladder cancer: past challenges and current innovations","volume":"4","author":"Railkar","year":"2018","journal-title":"Eur. Urol. Focus"},{"issue":"11","key":"10.1016\/j.ejmech.2024.116283_bib16","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1039\/C6CC09994G","article-title":"Efficient activation of a visible light-activatable CA4 prodrug through intermolecular photo-unclick chemistry in mitochondria","volume":"53","author":"Bio","year":"2017","journal-title":"Chem. Commun."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116283_bib17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.bmcl.2019.03.053","article-title":"Singlet oxygen-activatable Paclitaxel prodrugs via intermolecular activation for combined PDT and chemotherapy","volume":"29","author":"Bio","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"10","key":"10.1016\/j.ejmech.2024.116283_bib18","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1039\/C8OB02902D","article-title":"Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy","volume":"17","author":"Fernandes","year":"2019","journal-title":"Org. Biomol. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116283_bib19","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/acs.jmedchem.0c01677","article-title":"Facile synthesis of cyclic peptide-phthalocyanine conjugates for epidermal growth factor receptor-targeted photodynamic therapy","volume":"64","author":"Chu","year":"2021","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116283_bib20","first-page":"3448","article-title":"Glycosylated BODIPY- incorporated Pt(II) metallacycles for targeted and synergistic chemo-photodynamic therapy","volume":"66","author":"Dur\u00e1n-Sampedro","year":"2023","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116283_bib21","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1021\/acs.jmedchem.8b01927","article-title":"Epidermal growth factor receptor-targeted multifunctional photosensitizers for bladder cancer imaging and photodynamic therapy","volume":"62","author":"Cheruku","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116283_bib22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/cmdc.201402373","article-title":"Molecular-target-based anticancer photosensitizer: synthesis and in vitro photodynamic activity of erlotinib-zinc(II) phthalocyanine conjugates","volume":"10","author":"Zhang","year":"2015","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116283_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/acs.jmedchem.0c01735","article-title":"Synthesis, tumor specificity, and photosensitizing efficacy of erlotinib-conjugated chlorins and bacteriochlorins: identification of a highly effective candidate for photodynamic therapy of cancer","volume":"64","author":"Cheruku","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116283_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejmech.2019.02.065","article-title":"Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion","volume":"169","author":"Wei","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116283_bib25","first-page":"1284","article-title":"Synthesis and biological properties of EGFR-targeted photosensitizer based on cationic porphyrin","volume":"15","author":"Bortnevskaya","year":"2023","journal-title":"Pharm. Times"},{"key":"10.1016\/j.ejmech.2024.116283_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotochem.2022.114138","article-title":"Development of novel porphyrin\/combretastatin A-4 conjugates for bimodal chemo and photodynamic therapy: synthesis, photophysical and TDDFT computational studies","volume":"433","author":"Kuzmina","year":"2022","journal-title":"J. Photochem. Photobiol. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2024.116283_bib27","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1021\/acs.jmedchem.1c01254","article-title":"COUPY coumarins as novel mitochondria-targeted photodynamic therapy anticancer agents","volume":"64","author":"Ortega-Forte","year":"2021","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2024.116283_bib28","doi-asserted-by":"crossref","first-page":"19543","DOI":"10.1021\/acsami.1c02019","article-title":"Organelle-targeted photosensitizers for precision photodynamic therapy","volume":"13","author":"Wang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116283_bib29","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.jmedchem.1c01736","article-title":"A second near-infrared Ru(II) polypyridyl complex for synergistic chemo-photothermal therapy","volume":"65","author":"Liu","year":"2022","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116283_bib30","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1039\/C5SC00826C","article-title":"Image-guided combination chemotherapy and photodynamic therapy using a mitochondria-targeted molecular probe with aggregation-induced emission characteristics","volume":"6","author":"Zhang","year":"2015","journal-title":"Chem. Sci."},{"issue":"13","key":"10.1016\/j.ejmech.2024.116283_bib31","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.7150\/thno.16141","article-title":"X-ray induced photodynamic therapy: a combination of radiotherapy and photodynamic therapy","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116283_bib32","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1021\/acs.jmedchem.1c01953","article-title":"Conjugates of porphyrinoid-based photosensitizers with cytotoxic drugs: current progress and future directions toward selective photodynamic therapy","volume":"65","author":"Otvagin","year":"2022","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116283_bib33","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s12551-022-00962-6","article-title":"Advantages of combined photodynamic therapy in the treatment of oncological diseases","volume":"14","author":"Grin","year":"2022","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ejmech.2024.116283_bib34","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ejmech.2017.12.062","article-title":"Synthesis and biological evaluation of new water-soluble photoactive chlorin conjugate for targeted delivery","volume":"144","author":"Otvagin","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2024.116283_bib35","doi-asserted-by":"crossref","first-page":"11182","DOI":"10.1021\/acs.jmedchem.9b01294","article-title":"Water-soluble chlorin\/arylaminoquinazoline conjugate for photodynamic and targeted therapy","volume":"62","author":"Otvagin","year":"2019","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2024.116283_bib36","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1055\/s-0034-1378876","article-title":"Synthesis of chlorin\u2013(Arylamino)Quinazoline hybrids as models for multifunctional drug development","volume":"47","author":"Nyuchev","year":"2015","journal-title":"Synthesis"},{"issue":"55","key":"10.1016\/j.ejmech.2024.116283_bib37","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1039\/C8CC09456J","article-title":"Novel tumor and mitochondria dual-targeted photosensitizer showing ultra-efficient photodynamic anticancer activities","author":"Zhao","year":"2019","journal-title":"Chem. Commun."},{"issue":"261","key":"10.1016\/j.ejmech.2024.116283_bib38","article-title":"Novel chlorin e6-based conjugates of tyrosine kinase inhibitors: synthesis and photobiological evaluation as potent photosensitizers for photodynamic therapy","author":"Huang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"257","key":"10.1016\/j.ejmech.2024.116283_bib39","article-title":"A photosensitizer-inhibitor conjugate for photodynamic therapy with simultaneous inhibition of treatment escape pathways","author":"Xiao","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2024.116283_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejmech.2013.12.045","article-title":"\u03b2-Glucuronidase-Responsive prodrugs for selective cancer chemotherapy: an update","volume":"74","author":"Tranoy-Opalinski","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116283_bib41","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/bjc.1962.66","article-title":"Some investigations into the origin of the \u03b2-glucuronidase activity in the urine of patients with cancer of the bladder","volume":"16","author":"Haije","year":"1962","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2024.116283_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111921","article-title":"Therapeutic significance of \u03b2-glucuronidase activity and its inhibitors: a review","volume":"187","author":"Awolade","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116283_bib43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14737140.2017.1344553","article-title":"Cabozantinib for the treatment of kidney cancer","volume":"17","author":"Abdelaziz","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116283_bib44","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/1535-7163.MCT-11-0264","article-title":"Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth","volume":"10","author":"Yakes","year":"2011","journal-title":"Mol. Cancer Therapeut."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116283_bib45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.clgc.2021.04.001","article-title":"Cabozantinib plus durvalumab in patients with advanced urothelial carcinoma after platinum chemotherapy: safety and preliminary activity of the open-label, single-arm, phase 2 ARCADIA trial","volume":"19","author":"Marandino","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"issue":"8","key":"10.1016\/j.ejmech.2024.116283_bib46","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1470-2045(20)30202-3","article-title":"Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial","volume":"21","author":"Apolo","year":"2020","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116283_bib47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/phar.2076","article-title":"Cabozantinib: a multitargeted oral tyrosine kinase inhibitor","volume":"38","author":"Markowitz","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116283_bib48","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/bc0600214","article-title":"Development and properties of \u03b2-glucuronide linkers for monoclonal antibody-drug conjugates","volume":"17","author":"Jeffrey","year":"2006","journal-title":"Bioconjugate Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116283_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1021\/ml100039h","article-title":"Expanded utility of the \u03b2-glucuronide linker: ADCs that deliver phenolic cytotoxic agents","volume":"1","author":"Jeffrey","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.ejmech.2024.116283_bib50","doi-asserted-by":"crossref","first-page":"10261","DOI":"10.1021\/acs.chemrev.5b00244","article-title":"Glycosylated porphyrins, phthalocyanines, and other porphyrinoids for diagnostics and therapeutics","volume":"115","author":"Singh","year":"2015","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116283_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mencom.2020.03.009","article-title":"Synthesis and antiproliferative activity of new chlorin E6 glycoconjugates","volume":"30","author":"Kuzmina","year":"2020","journal-title":"Mendeleev Commun."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116283_bib52","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.metabol.2015.10.007","article-title":"Facilitative glucose transporters: implications for cancer detection, prognosis and treatment","volume":"65","author":"Barron","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.ejmech.2024.116283_bib53","series-title":"C-met Modulators and Methods of Use","author":"Bannen","year":"2012"},{"key":"10.1016\/j.ejmech.2024.116283_bib54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s13233-013-1038-1","article-title":"Synthesis and characterization of novel diglycidyl methacrylate-based macromonomers on isosorbide for dental composites","volume":"21","author":"Vazifehasl","year":"2013","journal-title":"Macromol. Res."},{"key":"10.1016\/j.ejmech.2024.116283_bib55","first-page":"1","article-title":"The use of taurine and D-glucurono-\u03b3-lactone as constituents of the so-called \u201cenergy\u201d drinks","volume":"935","author":"Aguilar","year":"2009","journal-title":"EFSA J."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116283_bib56","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1021\/ja209335z","article-title":"An activity-based near-infrared glucuronide trapping probe for imaging \u03b2-glucuronidase expression in deep tissues","volume":"134","author":"Cheng","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116283_bib57","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D\u2019souza","year":"2016","journal-title":"Expet Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116283_bib58","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.freeradbiomed.2011.12.027","article-title":"Combined effects of singlet oxygen and hydroxyl radical in photodynamic therapy with photostable bacteriochlorins: evidence from intracellular fluorescence and increased photodynamic efficacy in vitro","volume":"52","author":"D\u0105browski","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2024.116283_bib59","series-title":"Encyclopedia of Psychopharmacology","first-page":"1","article-title":"Lipophilicity","author":"Lindsley","year":"2010"},{"issue":"41","key":"10.1016\/j.ejmech.2024.116283_bib60","article-title":"Inner filter effect in fluorescence spectroscopy: as a problem and as a solution","author":"Panigrahi","year":"2019","journal-title":"J. Photochem. Photobiol., C: Photochemistry"},{"key":"10.1016\/j.ejmech.2024.116283_bib61","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejmech.2016.12.056","article-title":"A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy","volume":"127","author":"Ke","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116283_bib62","article-title":"The involvement of hepatocyte growth factor-MET-matrix metalloproteinase 1 signaling in bladder cancer invasiveness and proliferation. Effect of the MET inhibitor, cabozantinib (XL184)","volume":"101","author":"Shintani","year":"2017","journal-title":"on Bladder Cancer Cells, Urology"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116283_bib63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2013.04.042","article-title":"MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-met","volume":"435","author":"Hu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116283_bib64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.phrs.2017.01.024","article-title":"Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib","volume":"119","author":"Zhang","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116283_bib65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4161\/cbt.4.2.1440","article-title":"ABCG2-Mediated transport of photosensitizers: potential impact on photodynamic therapy","volume":"4","author":"Robey","year":"2005","journal-title":"Cancer Biol. Ther."},{"issue":"14","key":"10.1016\/j.ejmech.2024.116283_bib66","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1039\/D0CC06926D","article-title":"Rational design of a lysosome-targeting and near-infrared absorbing Ru(II)\u2013BODIPY conjugate for photodynamic therapy","volume":"57","author":"Qiao","year":"2021","journal-title":"Chem. Commun."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116283_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300139","article-title":"Lysosomes targeting PH activable imaging-guided photodynamic agents","volume":"24","author":"Figliola","year":"2023","journal-title":"Chembiochem"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116283_bib68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/php.12857","article-title":"Cell death pathways associated with photodynamic therapy: an update","volume":"94","author":"Kessel","year":"2018","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejmech.2024.116283_bib69","doi-asserted-by":"crossref","DOI":"10.1203\/00006450-200110000-00007","article-title":"A novel inhibitor of \u03b2-glucuronidase: l-aspartic acid","volume":"50","author":"Kreamer","year":"2001","journal-title":"Pediatr. Res."},{"issue":"23","key":"10.1016\/j.ejmech.2024.116283_bib70","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1158\/1078-0432.CCR-04-1087","article-title":"Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses","volume":"10","author":"Zhao","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116283_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jconrel.2015.07.020","article-title":"Life in 3D is never flat: 3D models to optimise drug delivery","volume":"215","author":"Fitzgerald","year":"2015","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116283_bib72","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","article-title":"Microenvironmental regulation of therapeutic response in cancer","volume":"25","author":"Klemm","year":"2015","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116283_bib73","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/biology12020204","article-title":"The multifaceted role of connexins in tumor microenvironment initiation and maintenance","volume":"12","author":"Kutova","year":"2023","journal-title":"Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116283_bib74","first-page":"401","article-title":"RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation","volume":"25","author":"Harding","year":"2007","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116283_bib75","first-page":"833","article-title":"An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer","volume":"19","author":"Naito","year":"2020","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116283_bib76","article-title":"Dynamic study of PDT-induced oxidative stress in cancer cells embedded in 3D collagen hydrogel using genetically encoded H2O2-sensor","volume":"8","author":"Sencha","year":"2022","journal-title":"J. Biomed. Photonics Eng."},{"issue":"16","key":"10.1016\/j.ejmech.2024.116283_bib77","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.3390\/ijms23168837","article-title":"Real-time fluorescence visualization and quantitation of cell growth and death in response to treatment in 3D collagen-based tumor model","volume":"23","author":"Sencha","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116283_bib78","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/biology9120446","article-title":"Comparative analysis of cell\u2013cell contact abundance in ovarian carcinoma cells cultured in two- and three-dimensional in vitro models","volume":"9","author":"Kutova","year":"2020","journal-title":"Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116283_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.drudis.2018.09.003","article-title":"3D in vitro models of tumors expressing EGFR family receptors: a potent tool for studying receptor biology and targeted drug development","volume":"24","author":"Sokolova","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2024.116283_bib80","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.freeradbiomed.2020.10.304","article-title":"Modeling the photodynamic effect in 2D versus 3D cell culture under normoxic and hypoxic conditions","volume":"162","author":"Kucinska","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116283_bib81","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00018-016-2401-0","article-title":"Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy","volume":"74","author":"Weijer","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116283_bib82","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10555-015-9588-7","article-title":"Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies","volume":"34","author":"Broekgaarden","year":"2015","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116283_bib83","first-page":"241","article-title":"EGFR-targeted photodynamic therapy","volume":"14","author":"Ulfo","year":"2022","journal-title":"Pharm. Times"},{"key":"10.1016\/j.ejmech.2024.116283_bib84","series-title":"Carbamate and Urea Compounds as Multikinase Inhibitors","author":"Wu","year":"2019"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116283_bib85","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1011-1344(03)00020-4","article-title":"Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy","volume":"69","author":"Bourr\u00e9","year":"2003","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.ejmech.2024.116283_bib86","first-page":"15","article-title":"LED light source for in vitro study of photosensitizing agents for photodynamic therapy","volume":"8","author":"Shilyagina","year":"2014","journal-title":"Sovrem. Tehnol. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116283_bib87","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0005-2736(95)00297-9","article-title":"Comparison of photosensitized Plasma membrane damage caused by singlet oxygen and free radicals","volume":"1280","author":"Kochevar","year":"1996","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2024.116283_bib88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424001636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424001636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:06:00Z","timestamp":1777529160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424001636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":88,"alternative-id":["S0223523424001636"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116283","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2023-fq4hv","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A first-in-class \u03b2-glucuronidase responsive conjugate for selective dual targeted and photodynamic therapy of bladder cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116283"}}